Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: Comparisons of four radiotherapy techniques

Cancer

Volumn 109, Issue 2, 2007, Pages 313-321

  Fang, Fu Min ^a,c   Tsai, Wen Ling ^b   Chen, Hui Chun ^a   Hsu, An Chih ^a   Hsiung, Ching Yeh ^a   Chien, Chih Yen ^a   Ko, Sheung Fat ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b YUNG TA INSTITUTE OF TECHNOLOGY AND COMMERCE   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Conformal radiotherapy; Intensity modulated radiotherapy; Nasopharyngeal carcinoma; Quality of life; Xerostomia

Indexed keywords

ADULT; ANOREXIA; ARTICLE; CANCER PATIENT; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; EATING; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PAIN ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SALIVA; SCORING SYSTEM; SPEECH; SYMPTOMATOLOGY; TOOTH; TREATMENT INDICATION; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; SOCIOECONOMIC FACTORS; SURVIVORS; TREATMENT OUTCOME; XEROSTOMIA;

EID: 33846251875     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22396     Document Type: Article

References (37)

1. Formosa Cancer Foundation. Annual Report 1999. Taipei, Taiwan: Formosa Cancer Foundation; 1999.
2. Teo PML, Ma BBY, Chan ATC. Radiotherapy for nasopharyngeal carcinoma-transition from two-dimensional to three-dimensional methods. Radiother Oncol. 2004;73:163-172.
3. Jen YM, Shih R, Lin YS, et al. Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: a dosimetric and clinical comparison with conventional radiotherapy. Radiother Oncol. 2005;75:204-209.
4. Chao KSC, Wippold FJ, Ozyigit G, Tran BN, Dempsey JF. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys. 2002;53:1174-1184.
5. Saarilahti K, Kouri M, Collan J, et al. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol. 2005;74:251-258.
6. Kwong DLW, Pow EHN, Sham JST, et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer. 2004;101:1584-1593.
7. Sultanem K, Shu HK, Xia P, et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys. 2000;48:711-722.
8. Xia P, Fu KK, Wong GW, Akazawa C, Verhey LJ. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000;48:329-337.
9. Lee N, Xia P Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12-22.
10. Wolden SL, Chen WC, Pfister DG, Kraus DH, Zelefsky MJ. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys. 2006;64:57-62.
11. Kam MKM, Teo PML, Chau RMC, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440-1450.
12. Sham JST, Wei WI. Nasopharyngeal carcinoma. Lancet. 2005;365:2041-2054.
13. Presant CA. Quality of life in cancer patients: who measures what? Am J Clin Oncol. 1984;7:571-573.
14. Kahn SB, Houts PS, Harding SP. Quality of life and patients with cancer: a comparative study of patients versus physicians perceptions and its implications for cancer education. J Cancer Educ. 1992;7:241-249.
15. Aronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-376.
16. Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al. Quality of life in head and neck cancer patients: validation of the EORTC H&N35. J Clin Oncol. 1999;17:1008-1019.
17. Hassan SJ, Weymuller EA Jr. Assessment of quality of life in head and neck cancer patients. Head Neck. 1997;19:169-175.
18. Cengiz M, Ozyar E, Esassolak M, et al. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules. Int J Radiat Oncol Biol Phys. 2005;63:1347-1353.
19. Fang FM, Chiu HC, Kuo WR, et al. Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment. Int J Radiat Oncol Biol Phys. 2002;53:959-968.
20. Fang FM, Leung SW, Wang CJ, et al. Computed tomography findings of bony regeneration after radiotherapy for nasopharyngeal carcinoma with skull base destruction: implications for local control. Int J Radiat Oncol Biol Phys. 1999;44:305-309.
21. Fang FM, Tsai WL, Ko SF, et al. Implications of quantitative tumor and nodal regression rates for nasopharyngeal carcinomas after 45 Gy of radiotherapy. Int J Radiat Oncol Biol Phys. 2001;50:961-969.
22. Hsiung CY, Yorke ED, Chui CS, et al. Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2002;53:638-647.
23. Hsiung CY, Hunt MA, Yorke ED, et al. Intensity-modulated radiotherapy as the boost or salvage treatment of nasopharyngeal carcinoma: the appropriate parameters in the inverse planning and the effect of patient's anatomic factors on the planning results. Radiother Oncol. 2005;77:53-57.
24. Fayers P, Aaronson NK, Bjordal K, et al. EORTC QLQ-C30 Scoring Manual. 2nd ed. Brussels, Belgium: EORTC Data Center; 1999.
25. King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res. 1996;5:555-567.
26. Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139-144.
27. Wolden SL, Zelefsky MJ, Hunt MA, et al. Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2001;49:1229-1234.
28. Epstein JB, Emerton S, Kolbinson DS, et al. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck. 1999;21;1-11.
29. Bjordal K, Kasa S, Matekaasa A. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys. 1994;28:847-855.
30. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys. 2003;57:61-70.
31. Parliament MB, Scrimger RA, Anderson SG, et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;58:663-673.
32. Jabbari S, Kim HM, Feng M, et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys. 2005;63:725-731.
33. Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:695-704.
34. Fisher J, Scott C, Scarantino C, et al. Phase III quality-of-life study results: impact of patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer-RTOG 97-09. Int J Radiat Oncol Biol Phys. 2005;56:832-836.
35. Ringash J, Warde P, Lockwood G, O'Sullivan B, Waldron J, Cummings B. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys. 2005;61:1403-1407.
36. McMillan AS, Pow EHN, Kwong DLW, et al. Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: results of a prospective longitudinal study. Head Neck. 2006;28:712-722.
37. Pan CC, Eisbruch A, Lee JS, Snorrason RM, Ten Haken RK, Kileny PR. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys. 2005;61:1393-1402.